Answers are grounded in this paper and cite their sources.
This project optimizes bioprinting parameters for a pectin-based bioink, suggesting potential for commercial production in tissue engineering.
Bioprinting for tissue engineering and regenerative medicine offers a promising solution to the growing demand for organ transplants. A pectin-based bioink was engineered to offer cost-effectiveness and operational simplicity. This project focuses on the commercialization and industrial production of this bioink. The bioink formulation and bioprinting parameters for extrusion-based bioprinting were optimized, as extrusion-based bioprinters are most commonly used in bioprinting. The optimization process focused on structural integrity, resolution, and cell viability. Additionally, an industrial-scale production process was designed using SuperPro Designer. The bioink formulation with optimized bioprinting parameters shows great potential for extrusion-based bioprinting with scalable manufacturing capabilities.
No takes yet. Share an insight, caveat, or question.
Berka et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: